EDGAR Filing Documents for 0001558370-20-002106

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-20-002106

Filing Date

2020-03-06

Accepted

2020-03-06 07:07:54

Documents

Period of Report

2019-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	mist-20191231x10k.htm	10-K	2986706
2	EX-4.3	mist-20191231ex43a48f010.htm	EX-4.3	23130
3	EX-23.1	mist-20191231ex231b9918c.htm	EX-23.1	8687
4	EX-31.1	mist-20191231ex31162aca5.htm	EX-31.1	13304
5	EX-31.2	mist-20191231ex312dee1ff.htm	EX-31.2	13296
6	EX-32.1	mist-20191231ex321109f9d.htm	EX-32.1	10717
7	GRAPHIC	mist20191231ex231b9918c001.jpg	GRAPHIC	2862
8	GRAPHIC	mist20191231x10k001.jpg	GRAPHIC	22486
9	GRAPHIC	mist20191231x10k002.jpg	GRAPHIC	10594
10	GRAPHIC	mist20191231x10k003.jpg	GRAPHIC	26072
11	GRAPHIC	mist20191231x10k004.jpg	GRAPHIC	32724
12	GRAPHIC	mist20191231x10k005.jpg	GRAPHIC	16811
13	GRAPHIC	mist20191231x10k006.jpg	GRAPHIC	22023
14	GRAPHIC	mist20191231x10k007.jpg	GRAPHIC	21391
15	GRAPHIC	mist20191231x10k008.jpg	GRAPHIC	32936
16	GRAPHIC	mist20191231x10k009.jpg	GRAPHIC	20460
17	GRAPHIC	mist20191231x10k010.jpg	GRAPHIC	32889
18	GRAPHIC	mist20191231x10k011.jpg	GRAPHIC	40990
	Complete submission text file	0001558370-20-002106.txt		8418315

Data Files

Seq	Description	Document	Type	Size
19	EX-101.INS	mist-20191231.xml	EX-101.INS	1478132
20	EX-101.SCH	mist-20191231.xsd	EX-101.SCH	52810
21	EX-101.CAL	mist-20191231_cal.xml	EX-101.CAL	49143
22	EX-101.DEF	mist-20191231_def.xml	EX-101.DEF	188405
23	EX-101.LAB	mist-20191231_lab.xml	EX-101.LAB	439728
24	EX-101.PRE	mist-20191231_pre.xml	EX-101.PRE	331215

Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6

Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444

Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)